Filing Details
- Accession Number:
- 0000899243-16-026291
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-04 15:30:16
- Reporting Period:
- 2016-08-02
- Filing Date:
- 2016-08-04
- Accepted Time:
- 2016-08-04 15:30:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1105533 | Argos Therapeutics Inc | ARGS | Pharmaceutical Preparations (2834) | 562110007 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1598754 | Public Joint Stock Co Pharmstandard | Likhacevsky Drive 5 &Quot;B&Quot; Dolgoprudny 1Z 141700 | No | No | Yes | No | |
1598762 | S.a. International Pharmstandard | 10A, Rue Henri Schnadt Luxembourg N4 L-2530 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-08-02 | 2,363,636 | $0.00 | 12,811,020 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant to Purchase Common Stock | Acquisiton | 2016-08-02 | 1,772,727 | $0.00 | 1,772,727 | $5.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,772,727 | 2016-08-02 | 2021-08-02 | No | 4 | P | Indirect |
Footnotes
- The reported securities were purchased by the Reporting Person for $5.50 per share of common stock and accompanying warrant. The shares of common stock and warrants were purchased in combination, with one warrant to purchase up to 0.75 of a share of common stock accompanying each share of common stock.
- Pharmstandard International S.A. is a wholly owned subsidiary of Public Joint Stock Company Pharmstandard. As the parent entity, Public Joint Stock Company Pharmstandard has voting power over the shares of the Issuer held by Pharmstandard International S.A.